Another successful divestment by PharmaVentures

Another successful divestment by PharmaVentures

PharmaVentures is pleased to announce that it has acted as advisor to one of the top US pharmaceutical companies in its divestment of one of its manufacturing facilities to a US contract manufacturer. The divestment, completed in mid-May, has led to the protection…

read more
Another successful divestment by PharmaVentures

PharmaVentures increases life science presence in the USA

OXFORD, England, February 11th 2015. PharmaVentures is pleased to announce that it is to increase its life science presence in North America by establishing a new base in Boston, MA. Starting this month Dr Adrian Dawkes, VP, will be dividing his time between the USA...

read more
Another successful divestment by PharmaVentures

PharmaVentures becomes latest Partner of One Nucleus

PharmaVentures has become the latest Partner to join forces with One Nucleus. Both PharmaVentures and One Nucleus are committed to playing an active and supportive role in assisting in the success of the life sciences sector nationally and internationally. 

read more
Another successful divestment by PharmaVentures

PharmaVentures increases its Asia-Pacific presence

OXFORD, UK, September 24th, 2014 PharmaVentures are delighted to announce that Aki von Roy has joined as an Associate, based in Auckland, New Zealand. He has over 30 years experience in Big Pharma and 16 years in biotech. Aki has been involved in over 18 start-up or...

read more